Abstract:Sarcoma is a malignant tumor originating from mesenchymal tissue with a poor prognosis. Atypical chemokine receptor 1 (ACKR1) is found closely related to cancer progression. However, the effects of ACKR1 in soft tissue sarcoma have not been well investigated. Therefore, our present study is devoted to analyze the functions of ACKR1 in sarcoma progression and its potential mechanism. We detected the expression of ACKR1 in the Cancer Genome Atlas (TCGA)-pan-cancer database, TCGA-Sarcoma from TCGA databases, and GSE21122 from Gene Expression Omnibus (GEO) database. The relationships between ACKR1 expression, clinicopathological data, and survival status were evaluated in the TCGA-Sarcoma database. Moreover, overexpression negative control (OE-NC) and overexpression ACKR1 (OE-ACKR1) were used to further verify the effects of ACKR1 overexpression in the progression of sarcoma cells by using Reverse Transcription-Quantitative Polymerase Chain Reaction (RT-qPCR), cell counting kit-8 (CCK-8), 5-Ethyny-2’-Deoxyuridine (EdU), wound healing, transwell assay, and flow cytometry assays. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and gene set enrichment analysis (GSEA) analyses were carried out to explore the potential enriched biological process of ACKR1 expression in sarcoma. Furthermore, tumor-immune system interactions databases (TISIDB) were applied to further confirm the relations between ACKR1 and tumor immune microenvironment in sarcoma. Our study found that ACKR1 is downregulated in multiple cancers (including sarcoma), and low expression of ACKR1 is related to poor survival status in sarcoma. The biological experiments found that promoting expression of ACKR1 can suppress sarcoma cell proliferation, migration, invasion, promote cell apoptosis, and arrest cell cycle. The GO-KEGG, GSEA, and TISIDB analysis showed that ACKR1 is related to the tumor immune microenvironment. In conclusion, low expression of ACKR1 presented as an independent prognostic biomarker in sarcoma. Overexpression of ACKR1 can significantly suppress cell progression ability in sarcoma by regulating the immune microenvironment.

Activated Cdc42-Associated Kinase is Up-Regulated in Non-Small-cell Lung Cancer and Necessary for FGFR-mediated AKT Activation.

ZYG11A Serves As an Oncogene in Non-Small Cell Lung Cancer and Influences CCNE1 Expression

[Phophorylated Akt Protein Expression in Non-Small Cell Lung Cancer].

Genome-wide Global Identification of NRF2 Binding Sites in A549 Non-Small Cell Lung Cancer Cells by ChIP-Seq Reveals NRF2 Regulation of Genes Involved in Focal Adhesion Pathways

ACY1 regulating PTEN/PI3K/AKT signaling in the promotion of non-small cell lung cancer progression

FGFR1 Regulates Proliferation and Metastasis by Targeting CCND1 in FGFR1 Amplified Lung Cancer

PDGFR‐β‐activated ACK1‐AKT Signaling Promotes Glioma Tumorigenesis

Inactivation of ABL kinases suppresses non-small cell lung cancer metastasis.

Akt kinase LANCL2 functions as a key driver in EGFR -mutant lung adenocarcinoma tumorigenesis

ACK1 is dispensable for development, skin tumor formation, and breast cancer cell proliferation

AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.

HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway

CRL2KLHDC3 mediates p14ARF N-terminal ubiquitylation degradation to promote non-small cell lung carcinoma progression

Ehf Enhances Malignancy By Modulating Akt And Mapk/Erk Signaling In Non-Small Cell Lung Cancer Cells

RACK1 Promotes Non-small-cell Lung Cancer Tumorigenicity through Activating Sonic Hedgehog Signaling Pathway

The Nucleolar Protein C1orf131 Is a Novel Gene Involved in the Progression of Lung Adenocarcinoma Cells through the AKT Signalling Pathway

High expression of ACKR1 predicts a good prognosis and suppresses sarcoma cell progression via regulating the tumor immune microenvironment

Long Noncoding RNA CTD-2245E15.3 Promotes Anabolic Enzymes ACC1 and PC to Support Non–Small Cell Lung Cancer Growth

Identification of NLE1/CDK1 Axis As Key Regulator in the Development and Progression of Non-Small Cell Lung Cancer

Notch1 activation promotes renal cell carcinoma growth via PI3K/Akt signaling.

Hgfk1 is Associated with A Better Prognostis and Reverses Inhibition by Gefitinib in Nsclc Cases